Automated Radiosynthesis Module Market Size, Share, Industry Trends, Latest Insights And Forecast 2024-2032

(MENAFN- IMARC Group) IMARC Group, a leading market research company, has recently releases report titled
“Automated Radiosynthesis Module Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032, ” The study provides a detailed analysis of the industry, including the
global automated radiosynthesis module market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the automated radiosynthesis module market ?

The global automated radiosynthesis module market size reached US$ 34.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.72% during 2024-2032.

Automated Radiosynthesis Modules (ARMs) are advanced medical equipment designed to automate the process of synthesizing radioactive isotopes with a tracer molecule that is suitable for performing intensive diagnostic and therapeutic procedures. It uses single-photon emission computerized tomography (SPECT) scanners and positron emission tomography (PET) for various medical applications. These modules incorporate cutting-edge engineering and sophisticated software to streamline and optimize the production of radiopharmaceuticals, ensuring accuracy, efficiency, and safety. Additionally, it allows the synthesis of complex molecules by integrating multiple steps into a single automated process, eliminating the need for manual intervention and reducing the risk of human error. At present, automated radiosynthesis is widely adopted in hospitals, diagnostic labs, and radiology clinics.

Request for a sample copy of this report:

What are the growth prospects and trends in the automated radiosynthesis module industry?

The market for automated radiosynthesis modules is primarily driven by the rising demand for personalized medicine and molecular imaging procedures. Additionally, the growing occurrences of chronic diseases such as cancer and neurological disorders are escalating the demand for targeted and precise diagnostic and therapeutic solutions, thus contributing to market growth. ARMs are essential, as they allow the efficient production of radiopharmaceuticals that can accurately diagnose diseases and deliver targeted treatments. Moreover, various advancements in nuclear medicine and positron emission tomography (PET) imaging techniques represent another major growth-inducing factor. Also, PET provides detailed and functional information about various diseases, and ARMs enable the synthesis of specific radiopharmaceuticals used in PET imaging, allowing for improved patient management, early disease detection, and treatment monitoring, propelling the market growth. Besides this, the widespread adoption of ARMs in the pharmaceutical industry on account of escalating demand for automated systems that ensure precision, reproducibility, and traceability in the production of radiopharmaceuticals is accelerating the product adoption rate.

What is included in market segmentation?

The report has segmented the market into the following categories:

Market Breakup by Type:

  • Fully Automated
  • Semi-Automated

Market Breakup by Application:

  • Hospitals
  • Diagnostic Labs
  • Radiology Clinics
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Elysia S.A.
  • General Electric Company
  • IBA RadioPharma Solutions
  • Optimized Radiochemical Applications
  • SCINTOMICS Molecular
  • Applied Theranostics Technologies GmbH
  • Synthra GmbH, Trasis

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact US:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.